Bausch + Lomb Second On Bausch Health IPO Card

Lumify, Ocuvite, PreserVision Drive Consumer Products 8% Q3 Sales Growth To $379M

Canadian firm plans to separate Solta first, with an IPO in December or January, and at least 30 days later offer shares in Bausch + Lomb. Order of IPOs could change, though.

• Source: Alamy

Bausch Health Companies Inc. decided on an initial public offering of shares to divest its Bausch + Lomb Inc. vision health business, but not until after an IPO for its Solta Medical aesthetic skin and body technology division.

The Canadian firm says it plans to separate Solta first, with an IPO in December or January, and at least...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Deals

More from Business